Abeona Therapeutics Receives Regulatory Approval to Initiate Clinical Trial in Australia with ABO-102 Gene Therapy … – Nasdaq
The Cerbat Gem |
Abeona Therapeutics Receives Regulatory Approval to Initiate Clinical Trial in Australia with ABO-102 Gene Therapy …
Nasdaq NEW YORK and CLEVELAND, May 09, 2017 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare diseases, today … Analysts See $-0.13 EPS for Abeona Therapeutics (ABEO); Profile of 6 Analysts Covering Diamond Offshore Drilling (DO) Zacks: Analysts Anticipate Abeona Therapeutics Inc (ABEO) Will Announce Earnings of -$0.13 Per Share Brokerages Set Abeona Therapeutics Inc (ABEO) PT at $16.83 |
